MCPHS/Biogen - Regulatory Sciences - Advertising and Promotion Fellowship - Post PharmD
MCPHS / Biogen
Location: Cambridge, Massachusetts
Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
Employer will assist with relocation costs.
Biogen, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which could enhance the potential for accelerated career development.
Regulatory Advertising and Promotion (Reg AP) is one of the functional groups within the Regulatory Sciences organization that support Biogen’s development and commercial programs. The Reg AP team is responsible for providing Biogen with strategic, high-quality, timely, and decisive regulatory advice on advertising and promotional materials, communications, and company activities in accordance with FDA and global health authority regulations, company policies, and business goals. The Reg AP group leads communications with regulatory agencies related to US advertising and promotion.
This 2-year Reg AP fellowship is designed to provide advanced, hands-on experience. The fellowship provides Reg AP professionals with comprehensive knowledge of regulations and real-world applications for advertising and promotion in the biopharmaceutical industry.
Regulatory AP is an area in which skills cannot be obtained solely from a professional degree; instead, the necessary knowledge is gained predominantly through on-the-job training and hands-on experience. Biogen recognizes this critical need for experienced Regulatory AP professionals and has partnered with the marketing department to offer a fellowship with opportunities to experience and learn the following:
The FDA regulations that govern advertising and promotion
How to apply regulations and provide guidance accurately and effectively
How promotional materials are developed through the commercial organization
The overall goal of the program is to prepare each fellow to be a successful Reg AP professional with a solid understanding of how FDA regulations are followed by the biopharmaceutical industry and enforced by the FDA. Upon completion of the fellowship, the experienced fellow will be well-prepared to enter an advanced career in Reg AP.
Elective Options The fellow will have the opportunity to select electives in other departments within Biogen, typically lasting 3 months each. Departments may include, but are not limited to:
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal will open up on October 3, 2022. Applicants must upload the following application materials to the online portal by November 11, 2022:
Letter of intent
Unofficial college transcript
Contact information for three references. References will receive an electronic recommendation form to complete separately.
Incomplete applications WILL NOT be reviewed. Interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendation evaluation forms must be submitted no later than December 1, 2022, via the online portal. This is NOT a letter of recommendation but an online form that the reference will need to complete.
Rolling Application Review & Interviews
All submitted applications will be reviewed on a rolling basis. Interviews will also be offered on a rolling basis and opportunities are limited. Priority will be given to those applicants who apply early, well in advance of the deadline.
Rolling interviews will begin mid-October with pre-screens and a mixture of interview rounds, and will conclude in December at the end of the ASHP Midyear Clinical Meeting. Candidates will be notified if selected for an interview.
ASHP Midyear & Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Las Vegas. Applicants are strongly encouraged to attend. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location pending COVID – 19 restrictions.
Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, MCPHS in conjunction with the Academic Industry Fellowship Alliance (AIFA), has agreed to extend offers for Fellowships no earlier than December 7, 2022.
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
About Biogen: At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide
innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related
therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by
Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today
Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment
for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research
programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders,
movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.
About MCPHS: MCPHS University provides an academic environment to guide and support fellows toward a successful career
in the biopharmaceutical industry. As a private institution with a history of specializing in the health sciences,
MCPHS University offers prog...rams that embody scholarship, professional service, and community outreach.
Through MCPHS University, the fellow will have the opportunity to gain teaching and research experience in an
academic setting. Throughout the program, MCPHS University faculty and company program leaders mentor
fellows according to each fellow’s scholarly and professional interests.